LOXL2 and diabetes mellitus: The observed increase at 11 weeks of LOXL2 expression was confirmed by various other HF studies other than diabetes, where the authors showed an increase in mRNA expression of LOXL2 was positively correlated with increased tissue fibrosis14,25,26.